MTHRF(MTHRF)
MTHRF
No analyst ratings available
No analyst price targets available for MTHRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $395.00B | $430.91B | $470.10B | $521.97B | $594.56B |
| Low | $380.43B | $409.15B | $449.42B | $499.01B | $568.41B |
| High | $407.96B | $447.89B | $487.15B | $540.89B | $616.12B |
| EBITDA Avg | $85.64B | $97.01B | $108.85B | $130.32B | $157.24B |
| Low | $80.91B | $91.74B | $102.99B | $123.33B | $148.81B |
| High | $89.54B | $101.36B | $113.68B | $136.08B | $164.19B |
| EBIT Avg | $83.45B | $92.96B | $103.10B | $122.93B | $148.16B |
| Low | $78.72B | $87.68B | $97.24B | $115.94B | $139.73B |
| High | $87.35B | $97.30B | $107.92B | $128.70B | $155.11B |
| Net Income Avg | $53.78B | $59.95B | $66.55B | $79.44B | $95.83B |
| Low | $50.70B | $56.53B | $62.74B | $74.90B | $90.35B |
| High | $56.31B | $62.78B | $69.68B | $83.18B | $100.35B |
| EPS Avg | $79.41 | $88.53 | $98.27 | $117.31 | $141.51 |
| Low | $74.87 | $83.47 | $92.65 | $110.60 | $133.42 |
| High | $83.15 | $92.71 | $102.90 | $122.83 | $148.18 |
| Analysts (Rev / EPS) | 13 / 1 | 13 / 1 | 8 / 1 | 11 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $94.14B | $105.52B | $99.59B |
| Low | $92.24B | $100.83B | $96.30B |
| High | $97.07B | $112.72B | $104.64B |
| EBITDA Avg | $24.10B | $28.92B | $25.25B |
| Low | $23.26B | $27.87B | $24.35B |
| High | $25.39B | $30.54B | $26.63B |
| EBIT Avg | $19.88B | $24.77B | $21.17B |
| Low | $19.04B | $23.72B | $20.27B |
| High | $21.17B | $26.38B | $22.55B |
| Net Income Avg | $12.73B | $15.91B | $13.58B |
| Low | $12.19B | $15.23B | $12.99B |
| High | $13.57B | $16.96B | $14.47B |
| EPS Avg | $19.07 | $23.84 | $20.33 |
| Low | $18.26 | $22.81 | $19.46 |
| High | $20.33 | $25.41 | $21.67 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 3 / 1 |